Nuformix plc

LSE (GBp): Nuformix plc (NFX)

Last Price

0.243

Today's Change

+0.018 (8.00%)

Day's Change

0.235 - 0.269

Trading Volume

9,939,221

Overview

Market Cap

5 Million

Shares Outstanding

2 Billion

Avg Volume

56,860,819

Avg Price (50 Days)

0.29

Avg Price (200 Days)

0.16

PE Ratio

0.00

EPS

0.00

Earnings Announcement

27-Jan-2026

Previous Close

0.23

Open

0.23

Day's Range

0.2348 - 0.2685

Year Range

0.042 - 0.555

Trading Volume

9,907,656

Price Change Highlight

1 Day Change

13.33%

5 Day Change

6.25%

1 Month Change

-8.93%

3 Month Change

75.86%

6 Month Change

200.00%

Ytd Change

410.00%

1 Year Change

410.00%

3 Year Change

-27.14%

5 Year Change

-91.05%

10 Year Change

-89.26%

Max Change

-90.29%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment